¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cell cycle restriction point"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • melting point
    ³ì´ÂÁ¡
  • melting point determination apparatus
    À¶Á¡ÃøÁ¤±â
  • mental point
    Åγ¡À¶±âÁ¡
  • mesiobuccoocclusal point angle
    ¾ÈÂʺ¼Âʱ³ÇÕ¸éÁ¡°¢
  • mesiolinguoocclusal point angle
    ¾ÈÂÊÇôÂʱ³ÇÕ¸éÁ¡°¢
  • near point
    ±ÙÁ¡
  • nodal point
    ±³Á¡, °áÀýÁ¡
  • null point
    Á¤ÁöÁ¡
  • ossification point
    »ÀµÇ±âÁß½É, °ñÈ­Áß½É
  • point
    Á¡
  • point charge
    Á¡ÇÏÀü
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • point prevalence
    ½ÃÁ¡À¯º´·ü
  • point sampling
    1. Á¡ÃßÃâ(¹ý) 2. Á¡Ç¥Áý
  • reference point
    ±âÁØÁ¡
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • cell line
    ¼¼Æ÷ÁÖ
  • giant cell pneumonia
    °Å´ë¼¼Æ÷Æó·Å
  • giant cell tumor
    °Å´ë¼¼Æ÷Á¾
  • granular cell tumor
    °ú¸³¼¼Æ÷Á¾¾ç
  • granulosa cell tumor
    °ú¸³Ãþ¼¼Æ÷Á¾¾ç
  • sickle cell trait
    ³´¼¼Æ÷¼ÒÁú, ³´ÀûÇ÷±¸Çü¼º¼ÒÁú
  • packed cell volume
    ÃæÀü¼¼Æ÷¿ëÀû, ³óÃ༼Æ÷¿ëÀû
  • red cell distribution width
    ÀûÇ÷±¸ºÐÆ÷Æø
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • three-point gait
    »ïÁ¡º¸Çà
  • two-point gait
    µÎÁ¡º¸Çà
  • trigger point injection
    À¯¹ßÁ¡ÁÖ»ç
  • jugomaxillary point
    ±¤´ë¾Õ¾Æ·¡Á¡, Çù»ó¾ÇÁ¡
  • lacrimal point
    ´«¹°Á¡
  • leak-point pressure
    ´©ÃâÁ¡¾Ð
  • leaking point
    »ùÁ¡, ´©ÃâÁ¡
  • malar point
    ±¤´ëÁ¡
  • melting point
    ³ì´ÂÁ¡
  • mental point
    (¢¡gnathion) Åγ¡À¶±âÁ¡
  • motor point
    ¿îµ¿Á¡
  • point mutation
    Á¡µ¹¿¬º¯ÀÌ
  • near point
    ±ÙÁ¡
  • nodal point
    ±³Á¡, °áÀýÁ¡
  • null point
    Á¤ÁöÁ¡
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • remote point
    ¿øÁ¡(êÀïÇ).
  • NK cell [=natural killer cell]
    ÀÚ¿¬»ì»ó¼¼Æ÷
  • alpha cell glucagon cell
    ¾ËÆÄ¼¼Æ÷ ±Û·çÄ«°ï¼¼Æ÷
  • quiescent cell, Q cell
    Á¤Áö¼¼Æ÷
  • A cell
    A ¼¼Æ÷
  • B cell
    B¼¼Æ÷(~ á¬øà)
  • B cell
    B ¼¼Æ÷
  • B cell
    B ¼¼Æ÷.
  • B cell antigen
    B ¼¼Æ÷Ç׿ø
  • B cell differentiation factor (BCDF)
    B¼¼Æ÷ ºÐÈ­À¯¹ßÀÎÀÚ
  • B cell growth factor
    B ¼¼Æ÷¼ºÀåÀÎÀÚ
  • B cell growth factor (BCGF)
    B¼¼Æ÷ Áõ½ÄÃËÁøÀÎÀÚ
  • B cell hybridoma
    B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
  • B cell lymphoma
    B¼¼Æ÷¸²ÇÁÁ¾
  • B cell stimulating factor (BSF)
    B¼¼Æ÷ ÀÚ±ØÀÎÀÚ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • growth cycle
    Áõ½ÄÁÖ±â
  • hair cycle
    ¸ð¹ßÁÖ±â(Ù¾ ñÎÑ¢)
  • hydrogen cycle
    ¼ö¼Òȯ(¡­ü»), ¼ö¼Ò°í¸®.
  • infection cycle
    °¨¿°»ç, °¨¿°È¯
  • intranuclear cycle
    ÇÙ³»»ýȰȯ.
  • life cycle
    »ýȰÁÖ±â
  • life cycle
    »ýȰÁÖ±â(~ñÎÑ¢)
  • life cycle
    »ýȰ»ç, »ýȰÁÖ±â, »ýȰȯ
  • male reproductive cycle
    ³²¼º»ý½ÄÁÖ±â
  • mammary cycle
    Á¥»ùÁÖ±â
  • menstrual cycle
    ¿ù°æÁÖ±â.
  • menstrual cycle
    ¿ù°æÁÖ±â
  • menstrual cycle, anovulatory
    ¿ù°æÁÖ±â(êÅÌèñÎÑ¢), ¹«¹è¶õ¼º(ÙíÛÉÕ°àõ)
  • metabolic cycle
    ´ë»çÁÖ±â.
  • mitotic cycle
    À¯»çºÐ¿­È¯(¡­ü»).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Stellate myoepithelial cell
    º°±ÙÀ°»óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ¼º»ó±Ù»óÇǼ¼Æ÷
  • Stellate cell
    º°¼¼Æ÷
    [¿¾ ¿ë¾î] ¼º»ó¼¼Æ÷
  • Cell of parathyroid gland
    ºÎ°©»ó»ù¼¼Æ÷
    [¿¾ ¿ë¾î] ºÎ°©»ó¼±¼¼Æ÷
  • Secretory synovial cell
    ºÐºñÀ±È°¼¼Æ÷
    [¿¾ ¿ë¾î] Ȱ¸·ºÐºñ¼¼Æ÷
  • Mast cell
    ºñ¸¸¼¼Æ÷
    [¿¾ ¿ë¾î] ºñ¸¸¼¼Æ÷
  • Intercalated epithelial cell
    »çÀÌ»óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] Áß°£Ãþ»óÇǼ¼Æ÷
  • Interstitial cell
    »çÀÌÁú¼¼Æ÷
    [¿¾ ¿ë¾î] °£Áú¼¼Æ÷
  • Epithelial reticular cell
    »óÇǼ¼¸Á¼¼Æ÷
    [¿¾ ¿ë¾î] »óÇǼº¼¼¸Á¼¼Æ÷
  • Pigment epithelial cell
    »ö¼Ò»óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] »ö¼Ò»óÇǼ¼Æ÷
  • Glandular cell
    »ù¼¼Æ÷
    [¿¾ ¿ë¾î] ¼±¼¼Æ÷
  • Ciliated ependymal cell
    ¼¶¸ð³ú½Ç¸·¼¼Æ÷
    [¿¾ ¿ë¾î] ¼¶¸ð»óÀǼ¼Æ÷
  • Ciliated epithelial cell
    ¼¶¸ð»óÇǼ¼Æ÷
    [¿¾ ¿ë¾î] ¼¶¸ð»óÇǼ¼Æ÷
  • Ciliated cell
    ¼¶¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ¼¶¸ð¼¼Æ÷
  • Apex of cell
    ¼¼Æ÷²À´ë±â
    [¿¾ ¿ë¾î] ¼¼Æ÷÷
  • Cell membrane
    ¼¼Æ÷¸·
    [¿¾ ¿ë¾î] ¼¼Æ÷¸·
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • glyoxylate cycle
    ±Û¶óÀÌ¿Á½Ç»ê(ß«) ȸ·Î(üÞÖØ)
  • Krebs cycle
    Å©·¾½º ȸ·Î(üÞÖØ)
  • Krebs-Henseleit cycle
    Å©·¾½º-Ç¶óÀÌÆ® ȸ·Î(üÞÖØ)
  • Krebs-Kornberg cycle
    Å©·¾½º-Äܹö±× ȸ·Î(üÞÖØ)
  • life cycle
    "»ýȰ»ç(ßæüÀÞÈ),»ýȰÁÖ±â(ßæüÀñÎÑ¢)"
  • lysogenic cycle
    ¿ë¿øÁÖ±â(éÁê«ñÎÑ¢)
  • lytic cycle
    ¿ëÇØÁÖ±â(éÁú°ñÎÑ¢)
  • Meister cycle
    ¸¶À̽ºÅÍ È¸·Î(üÞÖØ)
  • mitotic cycle
    À¯»çºÐ¿­ÁÖ±â(×¾ÞÄÝÂÖ®ñÎÑ¢)
  • multiplication cycle
    Áõ½Äȸ·Î(ñòãÖüÞÖØ)
  • nitrogen cycle
    Áú¼Òȸ·Î(òòáÈüÞÖØ)
  • nuclear cycle
    ÇÙÁÖ±â(ú·ñÎÑ¢)
  • ornithine cycle
    ¿À¸£´Ïƾ ȸ·Î(üÞÖØ)
  • oxygen cycle
    »ê¼Òȸ·Î(ß«áÈüÞÖØ)
  • pentose cycle
    "ÆæÅ佺(¿Àź´ç, çé÷©ÓØ) ȸ·Î(üÞÖØ)"
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
PCL pacing cycle length; persistent corpus luteum; plasma cell leukemia; posterior chamber lens; posteri...
SCL scleroderma; serum copper level; sinus cycle length; soft contact lens; stromal cell line; subcostal...
tG1 the time required to complete the G1 phase of the cell cycle
tG2 the time required to complete the G2 phase of the cell cycle
tM the time required to complete the M phase of the cell cycle
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
POCT Point of care testing
PRESS Point resolved spectroscopy
RIP Repeat Induced Point mutation
tsp Transcription start point
tsp Transcriptional start point
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • point of nociception
    Ä§ÇØ¼ö¿ë Á¡, À¯Çؼö¿ë Á¡
  • point of symmetry
    ´ëĪÁ¡. ¾È°ú,»ý¸®
  • point tenderness
    ±¹¼ÒÀû ¾ÐÅë
  • posterior focal point
    ÈÄ ÃÊÁ¡
  • posterior reference point
    ÈĹæ Âü°íÁ¡
  • round body tapered point
    ȯħ
  • satellate trigger point
    À§¼º ¹ßÅëÁ¡
  • satellite trigger point
    À§¼º ¹ßÅëÁ¡
  • silver point
    ÀºÁ¡
    ±¹Á¦ ¿Âµµ°è¿¡¼­ ÀºÀÇ ¾×»ó°ú °í»óÀÌ ÆòÇü »óŸ¦ ÀÌ·ç´Â ¿Âµµ·Î 960.8¡ÉÀÌ´Ù.
  • specific tender point site
    ƯÁ¤ ¾ÐÅëÁ¡
  • sulfur point
    Ȳ ºñÁ¡
  • supraauricular point
    ÀÌ»óÁ¡
  • tender point
    ¾ÐÅëÁ¡
    ·ù¸¶Æ¼ÁòÇп¡¼­ »ç¿ëµÇ´Â ¿ë¾î·Î¼­ ƯÀÌÇÏ°Ô ¼¶À¯ ±ÙÅë¿¡¼­ ÃËÁø¿¡ ´ëÇØ ÅëÁõÀ» ³ªÅ¸³¾ ¼ö ÀÖ´Â 9½ÖÀÇ ÇØºÎÇÐÀû À§Ä¡
  • trapezius trigger point
    ½Â¸ð±Ù ¹ßÅëÁ¡
  • trigger point
    ¹ßÅëÁ¡, À¯¹ßÁ¡
    ÀÚ±ØÀ» ¹ÞÀ¸¸é ¹Ýº¹ÀûÀ¸·Î ±Þ¼º ½Å°æÅ뼺 ÅëÁõÀ̳ª ÀüÀÌµÈ ±Ù°ñ°Ý¼º ÅëÁõÀ» À¯¹ßÇÏ´Â ÇǺγª ±ÙÀ°ÀÇ ¸ðµç ºÎÀ§ÀÌ´Ù. ÀÌ ¿ë¾î´Â 3Â÷ ½Å°æÅëÀ̳ª ±Ù¸· ÅëÁõ ¸ðµÎ¿¡¼­ »ç¿ëµÈ´Ù. myofascial trigger
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
urea cycle The metabolic pathway isfound in vertebrates and takes place in theliver, in it, urea is synthesised from amino acids and carbon dioxide.
(09 Oct 1997)
Krebs cycle <biochemistry> Tricarboxylic acid cycle or citric acid cycle.
(18 Nov 1997)
Krebs-Henseleit cycle The metabolic pathway isfound in vertebrates and takes place in theliver, in it, urea is synthesised from amino acids and carbon dioxide.
(09 Oct 1997)
Krebs-Kornberg cycle A catabolic cycle in plants and microorganisms like that of the tricarboxylic acid cycle in animals; its key reaction is the condensation of acetyl-CoA with glyoxylic acid to malic acid (analogous to the condensation of acetyl-CoA and oxaloacetic acid to form citric acid in the tricarboxylic acid cycle).
Synonym: Krebs-Kornberg cycle.
(05 Mar 2000)
forced cycle <cardiology, physiology> A cardiac cycle (atrial or ventricular) that is cut short by a forced beat.
(05 Mar 2000)
fuel cycle The series of steps required to produce electricity. The fuel cycle includes mining or otherwise acquiring the raw fuel source, processing and cleaning the fuel, transport, electricity generation, waste management and plant decommissioning.
(05 Dec 1998)
futile cycle <biochemistry> Any seqence of enzyme catalysed reactions in which the forward and reverse processes (catalysed by different enzymes) are consititutively active.
Frequently used to describe the cycle of phosphorylation and dephosphorylation of phosphatidyl inositol derivatives in cell membranes.
(05 Jan 1998)
levelised life-cycle cost The present value of the cost of a resource, including capital, financing and operating costs, expressed as a stream of equal annual payments. This stream of payments can be converted to a unit cost of energy by dividing the annual payment amount by the annual kilowatt-hours produced or saved. By levelizing costs, resources with different lifetimes and generating capabilities can be compared.
(05 Dec 1998)
life cycle The entire life history of a living organism.
(05 Mar 2000)
life-cycle costing A method of comparing costs of equipment or buildings based on original costs plus all operating and maintenance costs over the useful life of the equipment. Future costs are discounted.
(05 Dec 1998)
life cycle stages The continuous sequence of changes undergone by metamorphosing insects and other animals during the developmental process.
(12 Dec 1998)
lytic cycle The general life cycle of a lytic virus, from infection of the host cell, hijacking of the host cells mechanisms, use of the host cells mechanisms to produce viral components, and assembly of the components into progeny viruses, to the destruction of the host cell by rupturing its plasma membrane (lysis) and the release of the progeny viruses so that they can spread and infect other cells.
(09 Oct 1997)
T-cell-rich, B-cell lymphoma <tumour> A B-cell lymphoma in which more than 90% of the cells are of T-cell origin, masking the large cells that form the neoplastic B-cell component.
See: adult T-cell lymphoma.
(05 Mar 2000)
alveolar point The most anterior point on the maxillary alveolar process in the midline.
Synonym: alveolar point, prostheon.
Origin: G. Ntr. Of prosthios, foremost
(05 Mar 2000)
anterior focal point The point where parallel rays from the retina are focused.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • Point Four
    Á¦4Á¤Ã¥(Truman ´ëÅë·ÉÀÇ ¹Ì°³¹ß Áö¿ª °æÁ¦ ¿øÁ¶ Á¤Ã¥)
  • ball point pen
    º¼Ææ
  • black point
    Èæ¼öº´
  • boiling point
    ºñµîÁ¡
  • bradkeven point
    ä»êÁ¡
  • burning point
    ¹ßÈ­Á¡
  • cover point
    ÈÄÀ§
  • critical point
    ÀÓ°èÁ¡
  • dead point
    =DEAD CENTER
  • decimal point
    ¼Ò¼öÁ¡
  • dew point
    (±â»ó)(¿ÂµµÀÇ)À̽½Á¡;³ëÁ¡
  • dropoff point
    ¹è´Þǰ Àü´Þ Àå¼Ò;(À¯±« »ç°Ç µî¿¡¼­)¸ö°ªÀ» µÎ°í °¡´Â Àå¼Ò
  • end point
    Á¾·áÁ¡;Á¾Á¡;(È­)(ÀûÁ¤ÀÇ)Á¾Á¡;=ENDPOINT
  • equinoctial point
    (õ)ºÐÁ¡;ÁÖ¾ß ÆòºÐÁ¡
  • equitime point
    ÇൿÇѰèÁ¡;ÁøÃâ ÇѰèÁ¡
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á